Literature DB >> 15932249

Production of human alpha-1-antitrypsin from transgenic rice cell culture in a membrane bioreactor.

Karen A McDonald1, Lo Ming Hong, David M Trombly, Qing Xie, Alan P Jackman.   

Abstract

Transgenic plant cell cultures offer a number of advantages over alternative host expression systems, but so far relatively low product concentrations have been achieved. In this study, transgenic rice cells are used in a two-compartment membrane bioreactor (CELLine 350, Integra Biosciences) for the production of recombinant alpha-1-antitrypsin (rAAT). Expression of rAAT is controlled by the rice alpha-amylase (RAmy3D) promoter, which is induced in the absence of sugar. The extracellular product is retained in the bioreactor's relatively small cell compartment, thereby increasing product concentration. Due to the packed nature of the cell aggregates in the cell compartment, a clarified product solution can be withdrawn from the bioreactor. Active rAAT reached levels of 100-247 mg/L (4-10% of the total extracellular protein) in the cell compartment at 5-6 days postinduction, and multiple inductions of the RAmy3D promoter were demonstrated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932249     DOI: 10.1021/bp0496676

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  16 in total

1.  Adsorptive loss of secreted recombinant proteins in transgenic rice cell suspension cultures.

Authors:  Jun-Young Kwon; Kyoung-Hoon Lee; Su-Hwan Cheon; Hyun-Nam Ryu; Sun Jin Kim; Dong-Il Kim
Journal:  Plant Cell Rep       Date:  2011-11-11       Impact factor: 4.570

2.  Production of functional recombinant cyclic citrullinated peptide monoclonal antibody in transgenic rice cell suspension culture.

Authors:  Do Van Giap; Jae-Wan Jung; Nan-Sun Kim
Journal:  Transgenic Res       Date:  2019-02-11       Impact factor: 2.788

3.  On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.

Authors:  Jianfeng Xu; Ningning Zhang
Journal:  Pharm Bioprocess       Date:  2014-12-01

4.  The mucosal immune response to plant-derived vaccines.

Authors:  Kathleen Laura Hefferon
Journal:  Pharm Res       Date:  2010-05-14       Impact factor: 4.200

Review 5.  Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats.

Authors:  O Guttman; B M Baranovski; R Schuster; Z Kaner; G S Freixo-Lima; N Bahar; N Kalay; M I Mizrahi; I Brami; D E Ochayon; E C Lewis
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

6.  Immunomodulation by alpha(1)-proteinase inhibitor: lack of chemotactic effects of recombinant human alpha(1)-proteinase inhibitor from yeast on human peripheral blood granulocytes.

Authors:  Birgit Mosheimer; Reinhard Alzner; Christian J Wiedermann
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-12-03       Impact factor: 4.291

7.  Reaction of monocytes to polystyrene and silica nanoparticles in short-term and long-term exposures.

Authors:  Maria Mrakovcic; Claudia Meindl; Eva Roblegg; Eleonore Fröhlich
Journal:  Toxicol Res (Camb)       Date:  2014-03-01       Impact factor: 3.524

8.  Proteolytic and N-glycan processing of human α1-antitrypsin expressed in Nicotiana benthamiana.

Authors:  Alexandra Castilho; Markus Windwarder; Pia Gattinger; Lukas Mach; Richard Strasser; Friedrich Altmann; Herta Steinkellner
Journal:  Plant Physiol       Date:  2014-10-29       Impact factor: 8.340

Review 9.  Putting the Spotlight Back on Plant Suspension Cultures.

Authors:  Rita B Santos; Rita Abranches; Rainer Fischer; Markus Sack; Tanja Holland
Journal:  Front Plant Sci       Date:  2016-03-11       Impact factor: 5.753

Review 10.  Improving pharmaceutical protein production in Oryza sativa.

Authors:  Yu-Chieh Kuo; Chia-Chun Tan; Jung-Ting Ku; Wei-Cho Hsu; Sung-Chieh Su; Chung-An Lu; Li-Fen Huang
Journal:  Int J Mol Sci       Date:  2013-04-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.